Greenwich LifeSciences GLSI
NASDAQ GLSI
$17.35 -0.70 (-3.88%)
At close: Oct 1, 2026 · 4:00 PM EDT

Greenwich LifeSciences (GLSI) Return on Equity [ROE] (2020 - 2026)

Updated

Greenwich LifeSciences' Return on Equity [ROE] came in at -773.80% for Q1 2026, up 2415.39 percentage points from -3189.19% a year earlier and up 711.09 percentage points from the prior quarter.

Analysis

Greenwich LifeSciences (GLSI) Return on Equity [ROE] (2020 - 2026) Analysis & Trends

For FY2025, Greenwich LifeSciences' Return on Equity [ROE] was -3068.25%, down 2610.52 percentage points from FY2024.

  • Return on Equity [ROE] has declined in each of the last five years, with a five-year change of -3054.07 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Equity [ROE] was -457.72% in FY2024 (-368.43 pp), -89.30% in FY2023 (-50.22 pp), -39.08% in FY2022 (-22.30 pp) and -16.78% in FY2021 (-2.61 pp).
  • The Q1 2026 figure represents the highest quarterly Return on Equity [ROE] since Q4 2024.
  • Year-over-year, Return on Equity [ROE] increased in 1 of the last eight quarters, with an average year-over-year change of -660.36 percentage points.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in Q1 2026 (a gain of 2415.39 percentage points), and the weakest in Q1 2025 (a drop of 3032.86 percentage points).
  • Business Quant data shows GLSI's Return on Equity [ROE] at -1484.89% (Q4 2025), -1136.03% (Q3 2025) and -2329.84% (Q2 2025) in the three quarters before Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Greenwich LifeSciences 264.72 Mn 264.72 Mn - -773.80%
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -773.80%
Dec 31, 2025 -1,484.89%
Sep 30, 2025 -1,136.03%
Jun 30, 2025 -2,329.84%
Mar 31, 2025 -3,189.19%
Dec 31, 2024 -591.19%
Sep 30, 2024 -193.32%
Jun 30, 2024 -185.85%
Mar 31, 2024 -156.33%
Dec 31, 2023 -114.34%
Sep 30, 2023 -91.64%
Jun 30, 2023 -79.37%
Mar 31, 2023 -64.11%
Dec 31, 2022 -54.68%
Sep 30, 2022 -45.68%
Jun 30, 2022 -32.56%
Mar 31, 2022 -25.65%
Dec 31, 2021 -16.53%
Sep 30, 2021 -11.67%
Jun 30, 2021 -9.35%
API Access

Greenwich LifeSciences Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=GLSI&period=max&api_key=YOUR_API_KEY